Clinical Trial Update: Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

View source ↗

Summary

This clinical trial update describes the INCITE consortium's plan to integrate multiomics markers to identify invasive intraductal papillary mucinous neoplasms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasm of the Pancreas

Snippet

Sponsor: IRCCS San Raffaele | Conditions: IPMN, Pancreatic | Status: RECRUITING